Le document ci-dessous est la décision du Collège de la Haute Autorité de santé portant adoption de la recommandation intitulée « Stratégie de vaccination contre les infections invasives à méningocoques : révision de la stratégie contre les sérogroupes ACWY et B
See also
Public Health guideline
27/03/2024
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
UBzBPc7k9xDn6rjp
